Agilent Technologies Inc (A)
Agilent Technologies Inc (A) carries a ŷRobot AI score of 69 out of 100. The model's fair value estimate is $191.76, 10.1% above the last close of $174.09. The chart signal reads Bearish.
| Metric | A |
|---|---|
| AI score | 69 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $191.76 |
| Upside to fair value | 10.1% |
| Previous close | $174.09 |
| P/E | 34.59 |
| Price / sales | 6.37 |
| Market cap | $49.89B |
| EPS | 5.06 |
| Revenue growth | -0.0% |
| 1-year price change | 1.5% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about A
Is A overvalued or undervalued right now?
As of Oct 2, 2026, ŷRobot's fair-value model estimates Agilent Technologies Inc (A) at $191.76 against a last close of $174.09, implying 10.1% upside to the model's estimate.
Is A's chart signal bullish or bearish?
The chart-signal model classifies A as Neutral as of Nov 13, 2026, with a signal score of -0.10 on a -1 to 1 scale.
What is A's ŷRobot AI score?
A scores 69 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is A stock expensive on P/E and P/S?
A trades at 34.6 times earnings and 6.4 times sales as of Nov 13, 2026.
What does A's seasonal forecast show?
ŷRobot's seasonal forecast curve for A reads +4.4% at 30 days, -2.2% at 90 days, and +1.5% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is A growing?
Agilent Technologies Inc's revenue growth is -0.0% and free-cash-flow growth is +1.5% on the latest reported figures.
A chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.